Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

Goss CH, Kaneko Y, Khuu L, Anderson GD, Ravishankar S, Aitken ML, Lechtzin N, Zhou G, Czyz DM, McLean K, Olakanmi O, Shuman HA, Teresi M, Wilhelm E, Caldwell E, Salipante SJ, Hornick DB, Siehnel RJ, Becker L, Britigan BE, Singh PK.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaat7520. doi: 10.1126/scitranslmed.aat7520.

PMID:
30257953
2.

Correspondence between symptoms and preference-based health status measures in the STOP study.

Gold LS, Patrick DL, Hansen RN, Beckett V, Goss CH, Kessler L.

J Cyst Fibros. 2018 Aug 28. pii: S1569-1993(18)30743-4. doi: 10.1016/j.jcf.2018.08.001. [Epub ahead of print]

PMID:
30170756
3.

Benefits of set length antibiotic treatment for pulmonary exacerbations.

Goss CH, Somayaji R, Flume PA.

Lancet Respir Med. 2018 Aug;6(8):575-577. doi: 10.1016/S2213-2600(18)30267-4. Epub 2018 Jun 27. No abstract available.

PMID:
29960882
4.

Reply to Martelli et al.: eHealth in Cystic Fibrosis: Promising, but Proof of Concept Is Still Needed.

Lechtzin N, Mayer-Hamblett N, Khan U, Goss CH.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):285-286. doi: 10.1164/rccm.201803-0481LE. No abstract available.

PMID:
29698612
5.

The Long and the Short of It in Cystic Fibrosis Clinical Research Outcomes.

West NE, Goss CH, Nichols DP.

Ann Am Thorac Soc. 2018 Apr;15(4):430-431. doi: 10.1513/AnnalsATS.201801-056ED. No abstract available.

PMID:
29600892
6.

Changing Rates of Chronic Pseudomonas aeruginosa Infections in Cystic Fibrosis: A Population-Based Cohort Study.

Crull MR, Somayaji R, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, Nichols DP, Rowhani-Rahbar A, Goss CH.

Clin Infect Dis. 2018 Sep 14;67(7):1089-1095. doi: 10.1093/cid/ciy215.

PMID:
29534149
7.

Exploring Opportunities for Primary Outpatient Palliative Care for Adults with Cystic Fibrosis: A Mixed-Methods Study of Patients' Needs.

Hobler MR, Engelberg RA, Curtis JR, Ramos KJ, Zander MI, Howard SS, Goss CH, Aitken ML.

J Palliat Med. 2018 Apr;21(4):513-521. doi: 10.1089/jpm.2017.0259. Epub 2018 Jan 3.

PMID:
29298400
8.

Clinical characteristics of cystic fibrosis patients prior to lung transplantation: An international comparison between Canada and the United States.

Quon BS, Sykes J, Stanojevic S, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Faro A, Goss CH, Stephenson AL.

Clin Transplant. 2018 Mar;32(3):e13188. doi: 10.1111/ctr.13188. Epub 2018 Feb 11.

PMID:
29292522
9.

Epidemiology of CF: How registries can be used to advance our understanding of the CF population.

Jackson AD, Goss CH.

J Cyst Fibros. 2018 May;17(3):297-305. doi: 10.1016/j.jcf.2017.11.013. Epub 2017 Dec 21. Review.

PMID:
29275954
10.

Yet Again, Air Pollution Impacts Lung Health.

Sack CS, Goss CH.

Ann Am Thorac Soc. 2017 Dec;14(12):1761-1762. doi: 10.1513/AnnalsATS.201708-679ED. No abstract available.

PMID:
29192813
11.

Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.

Heltshe SL, West NE, VanDevanter DR, Sanders DB, Beckett VV, Flume PA, Goss CH; STOP Study Group.

Contemp Clin Trials. 2018 Jan;64:35-40. doi: 10.1016/j.cct.2017.11.012. Epub 2017 Nov 21.

PMID:
29170074
12.

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, Konstan MW, Morgan WJ, Pasta DJ, Moss RB.

J Cyst Fibros. 2018 Jul;17(4):503-510. doi: 10.1016/j.jcf.2017.10.003. Epub 2017 Oct 31.

PMID:
29100868
13.

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Goss CH, Sykes J, Stanojevic S, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Quon BS, Stephenson AL.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):768-775. doi: 10.1164/rccm.201707-1541OC.

PMID:
29099606
14.

Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis.

Hurley MN, Fogarty A, McKeever TM, Goss CH, Rosenfeld M, Smyth AR.

Ann Am Thorac Soc. 2018 Jan;15(1):42-48. doi: 10.1513/AnnalsATS.201705-376OC.

15.

Data that empower: The success and promise of CF patient registries.

Fink AK, Loeffler DR, Marshall BC, Goss CH, Morgan WJ.

Pediatr Pulmonol. 2017 Nov;52(S48):S44-S51. doi: 10.1002/ppul.23790. Epub 2017 Sep 14. Review.

PMID:
28910520
16.

Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Ramos KJ, Somayaji R, Nichols DP, Goss CH.

Paediatr Drugs. 2018 Feb;20(1):1-7. doi: 10.1007/s40272-017-0256-y. Review.

PMID:
28776129
17.

Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation.

Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML.

J Cyst Fibros. 2017 Nov;16(6):735-743. doi: 10.1016/j.jcf.2017.07.015. Epub 2017 Jul 28.

PMID:
28757079
18.

Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.

Lechtzin N, Mayer-Hamblett N, West NE, Allgood S, Wilhelm E, Khan U, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Gibson RL, Orenstein D, Milla C, Clancy JP, Antony V, Goss CH; eICE Study Team.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1144-1151. doi: 10.1164/rccm.201610-2172OC.

PMID:
28608719
19.

Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).

Somayaji R, Ramos KJ, Kapnadak SG, Aitken ML, Goss CH.

Presse Med. 2017 Jun;46(6 Pt 2):e109-e124. doi: 10.1016/j.lpm.2017.03.021. Epub 2017 May 26. Review.

PMID:
28554722
20.

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.

Sanders DB, Solomon GM, Beckett VV, West NE, Daines CL, Heltshe SL, VanDevanter DR, Spahr JE, Gibson RL, Nick JA, Marshall BC, Flume PA, Goss CH; STOP Study Group.

J Cyst Fibros. 2017 Sep;16(5):592-599. doi: 10.1016/j.jcf.2017.04.005. Epub 2017 Apr 29.

21.

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.

West NE, Beckett VV, Jain R, Sanders DB, Nick JA, Heltshe SL, Dasenbrook EC, VanDevanter DR, Solomon GM, Goss CH, Flume PA; STOP investigators.

J Cyst Fibros. 2017 Sep;16(5):600-606. doi: 10.1016/j.jcf.2017.04.003. Epub 2017 Apr 29.

PMID:
28457954
22.

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.

VanDevanter DR, Heltshe SL, Spahr J, Beckett VV, Daines CL, Dasenbrook EC, Gibson RL, Raksha J, Sanders DB, Goss CH, Flume PA; STOP Study Group.

J Cyst Fibros. 2017 Sep;16(5):607-615. doi: 10.1016/j.jcf.2017.04.004. Epub 2017 Apr 21.

PMID:
28438499
23.

Changes in acute pulmonary vascular responsiveness to hypoxia during a progressive ascent to high altitude (5300 m).

Luks AM, Levett D, Martin DS, Goss CH, Mitchell K, Fernandez BO, Feelisch M, Grocott MP, Swenson ER; Caudwell Xtreme Everest Investigators.

Exp Physiol. 2017 Jun 1;102(6):711-724. doi: 10.1113/EP086083. Epub 2017 May 21.

PMID:
28390080
24.

Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.

Somayaji R, Goss CH, Khan U, Neradilek M, Neuzil KM, Ortiz JR.

Clin Infect Dis. 2017 Jun 15;64(12):1760-1767. doi: 10.1093/cid/cix203.

25.

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Stephenson AL, Sykes J, Stanojevic S, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink AK, Elbert A, Goss CH.

Ann Intern Med. 2017 Apr 18;166(8):537-546. doi: 10.7326/M16-0858. Epub 2017 Mar 14.

26.

Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States.

Ramos KJ, Quon BS, Heltshe SL, Mayer-Hamblett N, Lease ED, Aitken ML, Weiss NS, Goss CH.

Chest. 2017 Jun;151(6):1320-1328. doi: 10.1016/j.chest.2017.01.019. Epub 2017 Jan 20.

27.

Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.

Ramos KJ, Somayaji R, Lease ED, Goss CH, Aitken ML.

BMC Pulm Med. 2017 Jan 19;17(1):21. doi: 10.1186/s12890-017-0367-9.

28.

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS.

Lancet Respir Med. 2017 Feb;5(2):107-118. doi: 10.1016/S2213-2600(16)30427-1. Epub 2016 Dec 21.

PMID:
28011037
29.

Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time.

Crull MR, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, Goss CH.

BMC Pulm Med. 2016 Dec 7;16(1):176.

30.

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett N, Zemanick ET, Hoover WC, VanDalfsen JM, Campbell P, Goss CH; STAR-too study team.

Thorax. 2017 Apr;72(4):318-326. doi: 10.1136/thoraxjnl-2016-208949. Epub 2016 Nov 15.

31.

Cystic Fibrosis is Associated with Adverse Neonatal Outcomes in Washington State, 1996-2013.

Ramos KJ, Sack CS, Mitchell KH, Goss CH, Starr JR.

J Pediatr. 2017 Jan;180:206-211.e1. doi: 10.1016/j.jpeds.2016.09.069. Epub 2016 Oct 25.

32.

An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.

Weiss CH, Krishnan JA, Au DH, Bender BG, Carson SS, Cattamanchi A, Cloutier MM, Cooke CR, Erickson K, George M, Gerald JK, Gerald LB, Goss CH, Gould MK, Hyzy R, Kahn JM, Mittman BS, Mosesón EM, Mularski RA, Parthasarathy S, Patel SR, Rand CS, Redeker NS, Reiss TF, Riekert KA, Rubenfeld GD, Tate JA, Wilson KC, Thomson CC; ATS Ad Hoc Committee on Implementation Science.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1015-1025.

33.

Cystic Fibrosis: The Dawn of a New Therapeutic Era.

Heltshe SL, Cogen J, Ramos KJ, Goss CH.

Am J Respir Crit Care Med. 2017 Apr 15;195(8):979-984. doi: 10.1164/rccm.201606-1250PP. No abstract available.

34.

With Every Upside, There Is a Downside: Chest Radiation and Survivors of Childhood Cancers.

Goss CH.

Ann Am Thorac Soc. 2016 Sep;13(9):1448-9. doi: 10.1513/AnnalsATS.201607-519ED. No abstract available.

35.

Nature versus Nurture: Does Genetic Ancestry Alter the Effect of Air Pollution in Children with Asthma?

Sack CS, Goss CH.

Am J Respir Crit Care Med. 2016 Jun 1;193(11):1196-8. doi: 10.1164/rccm.201601-0138ED. No abstract available.

36.

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, Elbert A, Petren KM, Marshall BC.

Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.

PMID:
27078236
37.

CFTR modulators and pregnancy: Our work has only just begun.

Goss CH, VanDevanter DR.

J Cyst Fibros. 2016 Jan;15(1):6-7. doi: 10.1016/j.jcf.2015.12.019. Epub 2016 Jan 7. No abstract available.

38.

Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.

Heltshe SL, Goss CH.

Thorax. 2016 Feb;71(2):101-2. doi: 10.1136/thoraxjnl-2015-208057. No abstract available.

39.

Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States.

Ramos KJ, Quon BS, Psoter KJ, Lease ED, Mayer-Hamblett N, Aitken ML, Goss CH.

J Cyst Fibros. 2016 Mar;15(2):196-203. doi: 10.1016/j.jcf.2015.11.005. Epub 2015 Dec 17.

40.

American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report.

Bender BG, Krishnan JA, Chambers DA, Cloutier MM, Riekert KA, Rand CS, Schatz M, Thomson CC, Wilson SR, Apter A, Carson SS, George M, Gerald JK, Gerald L, Goss CH, Okelo SO, Mularski RA, Nguyen HQ, Patel MR, Szefler SJ, Weiss CH, Wilson KC, Freemer M.

Ann Am Thorac Soc. 2015 Dec;12(12):S213-21. doi: 10.1513/AnnalsATS.201506-367OT. Review.

41.

A 21-Year-Old Woman With Cystic Fibrosis, Abdominal Pain, and Recent Weight Loss.

Kapnadak SG, Goss CH, Aitken ML.

Chest. 2015 Nov;148(5):e156-e160. doi: 10.1378/chest.15-1124.

PMID:
26527444
42.

It Starts at the Beginning: Effect of Particulate Matter In Utero.

Sack C, Goss CH.

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1025-6. doi: 10.1164/rccm.201507-1468ED. No abstract available.

43.

Correction: Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011.

Goss LB, Ortiz JR, Okamura DM, Hayward K, Goss CH.

PLoS One. 2015 Oct 9;10(10):e0140698. doi: 10.1371/journal.pone.0140698. eCollection 2015. No abstract available.

44.

A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts.

Sykes J, Stanojevic S, Goss CH, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Stephenson AL.

J Clin Epidemiol. 2016 Feb;70:206-13. doi: 10.1016/j.jclinepi.2015.08.026. Epub 2015 Oct 3.

45.

Country to country variation: what can be learnt from national cystic fibrosis registries.

Goss CH.

Curr Opin Pulm Med. 2015 Nov;21(6):585-90. doi: 10.1097/MCP.0000000000000208. Review.

PMID:
26390334
46.
47.

Tackling the increasing complexity of CF care.

Sawicki GS, Goss CH.

Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S74-9. doi: 10.1002/ppul.23244. Review.

48.

EBOLA VIRUS DISEASE.

Goss JF, Goss CH.

JEMS. 2015 May;40(5):59-63. No abstract available.

PMID:
26302646
49.

Remarkable long-term survival post-lung transplantation among Canadian patients with cystic fibrosis.

Ramos KJ, Goss CH.

J Heart Lung Transplant. 2015 Sep;34(9):1131-3. doi: 10.1016/j.healun.2015.05.010. Epub 2015 Jun 10. No abstract available.

PMID:
26169665
50.

Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011.

Goss LB, Ortiz JR, Okamura DM, Hayward K, Goss CH.

PLoS One. 2015 Jun 18;10(6):e0128920. doi: 10.1371/journal.pone.0128920. eCollection 2015. Corrected and republished in: PLoS One. 2015;10(10):e0140698.

Supplemental Content

Support Center